ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 108 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $24,000 | +84.6% | 7,257 | +128.9% | 0.00% | – |
Q1 2024 | $13,000 | -85.7% | 3,170 | -89.3% | 0.00% | – |
Q4 2023 | $91,000 | +116.7% | 29,609 | +111.1% | 0.00% | – |
Q3 2023 | $42,000 | +40.0% | 14,024 | +75.3% | 0.00% | – |
Q2 2023 | $30,000 | +57.9% | 7,998 | +38.5% | 0.00% | – |
Q1 2023 | $19,000 | -63.5% | 5,774 | -45.9% | 0.00% | – |
Q4 2022 | $52,000 | +100.0% | 10,664 | +135.1% | 0.00% | – |
Q3 2022 | $26,000 | +73.3% | 4,536 | +123.6% | 0.00% | – |
Q2 2022 | $15,000 | -63.4% | 2,029 | -63.6% | 0.00% | – |
Q1 2022 | $41,000 | -59.0% | 5,568 | -50.5% | 0.00% | – |
Q4 2021 | $100,000 | -65.5% | 11,249 | +36.4% | 0.00% | – |
Q3 2021 | $290,000 | +118.0% | 8,247 | +33.9% | 0.00% | – |
Q2 2021 | $133,000 | +121.7% | 6,157 | +530.2% | 0.00% | – |
Q1 2021 | $60,000 | +300.0% | 977 | +169.9% | 0.00% | – |
Q4 2020 | $15,000 | – | 362 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
CM Management, LLC | 270,000 | $823,500 | 0.66% |
EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
Auour Investments LLC | 177,000 | $670,830 | 0.26% |